Just like online reviews for the coffee shop around the corner, patients are rating physicians on both independent and health system websites. A study in the Journal of General Internal Medicine, published by Springer, examines how these rating systems effect physician stress levels and how both parties view the online review process.

CMS is offering a more modest 0.25 percent increase in payment rates for Medicare Advantage (MA) insurers, one year after a 0.85 percent hike, in its proposed MA update for 2018. 

John Holland, a former senior vice president for Tenet Healthcare’s southern region, has been charged with allegedly taking part in a scheme to pay bribes in exchange for patient referrals and resulting in $400 million in fraudulent Medicaid billings. 

AMGA is pleased that the Centers for Medicare & Medicaid Services (CMS) is not proposing to move forward with a more aggressive use of Medicare Advantage (MA) encounter data for risk adjustment as part of its Advance Notice of Methodological Changes for Calendar Year 2018 Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2017 Call Letter.

Individuals with anxiety or social disorders such as Asperger syndrome experience difficulties communicating with others. Researchers from MIT's Computer Science and Artificial Intelligence Laboratory (CSAIL) and Institute of Medical Engineering and Science (IMES) have developed a wearable device capable of predicting if conversations are happy, sad or neutral to improve communication.

There are guidelines about how many hours interns and more senior residents can work in a day or week. Many, however, go past those limits and lie about it.

Lower inpatient admission rates at hospitals seemed to correlate to higher rates of unexpected deaths within seven days of discharge from an emergency department, according to a new study published in BMJ.

Aetna CEO Mark Bertolini said the uncertainty surrounding the Affordable Care Act (ACA) and its insurance marketplace is too big of a risk for his company, saying it has “no intention of being in the market for 2018.”